RE: Bull and Bear points - discuss21 Feb 2024 22:20
Such nonsense. the options are tiny in the scale of the business. The business model is so 'questionable' that hvo are rolling in big contracts from some of the world's largest pharmaceutical companies. Those companies are so keen for the hvivo offering that they helped fund the facility which will give hvo a big growth and margin runway.
Did you sell too early? Trying to talk down a better entry level?